Harvest Fund Management Co., LTD Regeneron Pharmaceuticals, Inc. Transaction History
Harvest Fund Management Co., LTD
- $1.66 Billion
- Q3 2024
A detailed history of Harvest Fund Management Co., LTD transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Harvest Fund Management Co., LTD holds 4,994 shares of REGN stock, worth $3.56 Million. This represents 0.32% of its overall portfolio holdings.
Number of Shares
4,994
Previous 3,471
43.88%
Holding current value
$3.56 Million
Previous $3.65 Million
43.89%
% of portfolio
0.32%
Previous 0.27%
Shares
23 transactions
Others Institutions Holding REGN
# of Institutions
1,534Shares Held
83.6MCall Options Held
1.22MPut Options Held
1.51M-
Vanguard Group Inc Valley Forge, PA9.32MShares$6.64 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$6.02 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$5.34 Billion0.64% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.49 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.3MShares$3.06 Billion0.72% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $76.4B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...